The GIP/GLP-1-receptor agonist tirzepatide was approved for the treatment of T2D by the Food and Drug Administration (FDA) in the USA for once-weekly subcutaneous injections in May 2022 and has just received a positive opinion from the European Medicines Agency (EMA)
This, she argued, reframes hunger from a signal of survival into something medicine can mute at willforcing us to ask what it means to pharmacologically control desire
The structure of microbiota is controlled by the interaction of environmental factors, gut traits, host immune status, and chemical-physical surroundings
Accessed 05 February 2018
So, whether its a grilled chicken salad, a fish taco, or a veggie omelet, youre not just satisfying your taste buds but also giving a high-five to your metabolism